Skip to main content
. 2015 Jan 7;62(1):32–39. doi: 10.1002/jmrs.91

Figure 4.

Figure 4

Trendline showing the lifetime attributable risk (LAR) of developing secondary cancer in the contralateral breast relative to breast volume for treatment alone and treatment plus daily imaging with the megavoltage computed tomography (MV-CT), megavoltage electronic portal image (MV-EPI) and megavoltage cone-beam CT (MV-CBCT).